Mongolia vs Slovak Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Mongolia
96.0%
in 2025
Slovak Republic
96.0%
in 2025
Mongolia rank
26th
Slovak Republic rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Mongolia
- Slovak Republic
How they compare
Mongolia currently reports 96.0% against 96.0% in Slovak Republic, a difference of 0.0%.
Across all 18 years both countries report, Slovak Republic has been ahead every year.
Mongolia ranks 26th and Slovak Republic ranks 26th of 192 countries.
Slovak Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mongolia | Slovak Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 49.5% | 49.5% | Slovak Republic |
| 2010s | 8.8% | 97.3% | 88.5% | Slovak Republic |
| 2020s | 94.8% | 96.2% | 1.3% | Slovak Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Mongolia or Slovak Republic?
- Mongolia, at 96.0% against 96.0% in Slovak Republic as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Mongolia and Slovak Republic?
- 0.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Slovak Republic?
- 18 years are reported by both, from 2008 to 2025.
- How do Mongolia and Slovak Republic rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mongolia ranks 26th and Slovak Republic ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.